Harmony Biosciences Holdings, Inc. (HRMY)
27.74
-0.22
(-0.79%)
USD |
NASDAQ |
Apr 02, 16:00
27.74
0.00 (0.00%)
Pre-Market: 20:00
Harmony Biosciences Holdings Research and Development Expense (TTM) : 189.59M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Castle Biosciences, Inc. | 51.50M |
| BioMarin Pharmaceutical, Inc. | 700.97M |
| Amicus Therapeutics, Inc. | 135.84M |
| Iovance Biotherapeutics, Inc. | 302.62M |
| Apellis Pharmaceuticals, Inc. | 295.85M |